-
Study
Drug Augmentation in Schizophrenic or Schizoaffective Patients
with Depressive or
Negative Symptoms who are Partial or Nonresponders to Study
Drug.
-
A
Double-Blind, Randomized Trial of Three Fixed Doses of Transdermal
Study Drug Compared to Placebo in the Treatment of Anxious
Outpatients.
-
Study
Drug in the Management of Behavioral Disturbances and/or Psychosis
in Demented
Nursing Home Patients.
-
A
Double-Blind, Placebo-Controlled Study of Study Drug in the
Treatment of Signs and
Symptoms of Mania in Elderly Patients with Dementia.
-
An
Open-Label Extension Study of Study Drug in the Treatment
of Signs and Symptoms of
Mania in Elderly Patients with Dementia.
-
A
Double-Blind, Five-Armed, Fixed-Dose, Active and Placebo Controlled
Dose-Finding Study with Sublingual Study Drug in Subjects
with Acute Phase Schizophrenia.
-
Study
Drug for Humanitarian Use. (Schizophrenia)
-
A
Multicenter, Open-Label, Long-Term Safety and Efficacy Study
of Study Drug Tablets Once Daily in Subjects with Schizophrenia
or Other Psychotic Disorders.
-
A
Double-Blind, Placebo-Controlled, Parallel Assessment of the
Safety and Efficacy of the Study Drug Transdermal System in
Subjects with Major Depression.
-
An
Open-Label Study to Assess the Safety and Effectiveness of
the Study Drug Transdermal
System in Patients with Major Depression.
-
A
Multicenter, Double-Blind, Placebo-Controlled, Randomized
Trial and an Open-Label
Long-Term Tolerability Trial of Study Drug for the Acute Treatment
of Migraine Headaches in Adolescent Subjects.
-
A
Study of Low-Dose Study Drug in Patients with Generalized
Anxiety Disorder; A
Randomized, Double- Blind, Placebo-Controlled, Parallel-Group,
Multicenter Study to Assess Efficacy and Safety.
